Patents by Inventor Josephe Honorat

Josephe Honorat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Autoantibodies to Septin-7 and diagnosis of neurological disease
    Patent number: 11835519
    Abstract: A method for diagnosing a disease can include detecting, in a sample from a patient, an autoantibody binding to Septin-7. A polypeptide comprising Septin-7 or a variant thereof can be used for the diagnosis of a disease. Preferably, the polypeptide is used to detect an autoantibody binding to Septin-7 in a sample. A kit is useful for the diagnosis of a disease. The kit may include a polypeptide that includes Septin-7 or a variant thereof or a medical device that includes a polypeptide that includes Septin-7 or a variant thereof and an autoantibody to Septin-7.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: December 5, 2023
    Assignees: EUROIMMUN Medizinische Labordiagnostika AG, Mayo Foundation for Medical Education and Research
    Inventors: Ramona Miske, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Stefanie Hahn, Christiane Radzimski, Mandy Unger, Andrew McKeon, Sean Pittock, Thomas Kryzer, Vanda Lennon, Josephe Honorat
  • ASSESSING AND TREATING AUTOIMMUNE ATAXIA
    Publication number: 20230039907
    Abstract: Methods and materials herein are useful for assessing and/or treating autoimmune ataxias associated with septin-specific autoantibodies septin-5-specific autoantibodies For example, septin-5 polypeptides are provided as well as methods for using septin-5 polypeptides to detect septin-5-specific autoantibodies and/or to treat a mammal having an autoimmune ataxia.
    Type: Application
    Filed: September 30, 2022
    Publication date: February 9, 2023
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Josephe A. HONORAT, Andrew McKeon, Sean J. Pittock, Vanda A. Lennon
  • Assessing and treating autoimmune ataxia
    Patent number: 11493513
    Abstract: Methods and materials herein are useful for assessing and/or treating autoimmune ataxias associated with septin-specific autoantibodies (e.g., septin-5-specific autoantibodies). For example, septin-5 polypeptides are provided as well as methods for using septin-5 polypeptides to detect septin-5-specific autoantibodies and/or to treat a mammal having an autoimmune ataxia.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: November 8, 2022
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Josephe A. Honorat, Andrew McKeon, Sean J. Pittock, Vanda A. Lennon
  • ASSESSING AND TREATING AUTOIMMUNE ATAXIA
    Publication number: 20210311047
    Abstract: Methods and materials herein are useful for assessing and/or treating autoimmune ataxics associated with septin-specific autoantibodies (e.g., septin-5-specific autoantibodies). For example, septin-5 polypeptides are provided as well as methods for using septin-5 polypeptides to detect septin-5-specific autoantibodies and/or to treat a mammal having an autoimmune ataxia.
    Type: Application
    Filed: May 21, 2019
    Publication date: October 7, 2021
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Josephe A. HONORAT, Andrew McKeon, Sean J. Pittock, Vanda A, Lennon
  • Diagnosis of a neurological disease
    Publication number: 20210181196
    Abstract: A method for diagnosing a disease can include detecting, in a sample from a patient, an autoantibody binding to Septin-7. A polypeptide comprising Septin-7 or a variant thereof can be used for the diagnosis of a disease. Preferably, the polypeptide is used to detect an autoantibody binding to Septin-7 in a sample. A kit is useful for the diagnosis of a disease. The kit may include a polypeptide that includes Septin-7 or a variant thereof or a medical device that includes a polypeptide that includes Septin-7 or a variant thereof and an autoantibody to Septin-7.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 17, 2021
    Applicants: EUROIMMUN Medizinische Labordiagnostika AG, Mayo Foundation for Medical Education and Research
    Inventors: Ramona MISKE, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Stefanie Hahn, Christiane Radzimski, Mandy Unger, Andrew McKeon, Sean Pittock, Thomas Kryzer, Vanda Lennon, Josephe Honorat